language:
Find link is a tool written by Edward Betts.searching for Steatohepatitis 135 found (175 total)
alternate case: steatohepatitis
Alcoholic liver disease
(2,879 words)
[view diff]
no match in snippet
view article
find links to article
Alcoholic liver disease (ALD), also called alcohol-related liver disease (ARLD), is a term that encompasses the liver manifestations of alcohol overconsumptionObeticholic acid (1,997 words) [view diff] exact match in snippet view article find links to article
disease progression, liver transplantation or death. Non-alcoholic steatohepatitis is a common cause of abnormal liver function with histological featuresIntercept Pharmaceuticals (886 words) [view diff] exact match in snippet view article find links to article
biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitisCenicriviroc (560 words) [view diff] exact match in snippet view article find links to article
HIV infection and in combination with Tropifexor for non-alcoholic steatohepatitis. It is being developed by Takeda and Tobira Therapeutics.[citationSemaglutide (7,521 words) [view diff] exact match in snippet view article find links to article
weight loss, and the treatment of metabolic-associated steatohepatitis (nonalcoholic steatohepatitis). Semaglutide is a glucagon-like peptide-1 receptorApararenone (144 words) [view diff] exact match in snippet view article find links to article
Pharma for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. It was also previously being developed for the treatment of hypertensionCilofexor (370 words) [view diff] exact match in snippet view article find links to article
treatment of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and primary sclerosing cholangitis (PSC). It is being investigatedNidufexor (126 words) [view diff] exact match in snippet view article find links to article
trials for the treatment of diabetic nephropathy and nonalcoholic steatohepatitis. GSK-4112 SR9009 SR9011 Chianelli D, Rucker PV, Roland J, Tully DCAST/ALT ratio (979 words) [view diff] exact match in snippet view article find links to article
elevated in a liver disease pattern in patients with nonalcoholic steatohepatitis, and it is frequently elevated in an alcoholic liver disease patternRemogliflozin etabonate (710 words) [view diff] exact match in snippet view article find links to article
is a drug of the gliflozin class for the treatment of non-alcoholic steatohepatitis ("NASH") and type 2 diabetes. Remogliflozin was discovered by the JapaneseTropifexor (259 words) [view diff] exact match in snippet view article find links to article
developed for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH). In combination with cenicriviroc, a CCR2 and CCR5 receptorFocal fatty liver (123 words) [view diff] exact match in snippet view article find links to article
liver. It is likely to have different pathogenesis than non-alcoholic steatohepatitis which is a diffuse process. FFL may result from altered venous flowKupffer cell (2,352 words) [view diff] exact match in snippet view article find links to article
alcoholic liver disease, viral hepatitis, intrahepatic cholestasis, steatohepatitis, activation or rejection of the liver during liver transplantationCirrhosis (12,482 words) [view diff] exact match in snippet view article find links to article
including alcohol-related liver disease, metabolic dysfunction–associated steatohepatitis (MASH – the progressive form of metabolic dysfunction–associated steatoticTestosterone undecanoate (3,697 words) [view diff] exact match in snippet view article find links to article
intramuscular testosterone undecanoate for the treatment of non-alcoholic steatohepatitis (NASH) was initiated in the United Kingdom. In the United States inThiazolidinedione (2,172 words) [view diff] exact match in snippet view article find links to article
out since 2005 in polycystic ovary syndrome (PCOS), non-alcoholic steatohepatitis (NASH), psoriasis, autism, ovarian hyperstimulation syndrome (by VEGFRev-Erb (959 words) [view diff] exact match in snippet view article find links to article
family name. The receptors are potential drug targets for non-alcoholic steatohepatitis. Key functions of REV-ERB alpha and REV-ERB beta circadian proteinsMetabolic dysfunction–associated steatotic liver disease (15,500 words) [view diff] exact match in snippet view article find links to article
fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH, now known as metabolic dysfunction associated steatohepatitis (MASH)) have been used to describeEmricasan (473 words) [view diff] exact match in snippet view article find links to article
fast track designation by the FDA for the treatment of non-alcoholic steatohepatitis cirrhosis The substance is the first pan-caspase inhibitor to advanceTOR1AIP1 (813 words) [view diff] exact match in snippet view article find links to article
secretion and causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis GRCh38: Ensembl release 89: ENSG00000143337 – Ensembl, May 2017 GRCm38:Schrödinger, Inc. (809 words) [view diff] exact match in snippet view article find links to article
inhibitor was moving through late-stage clinical trials in non-alcoholic steatohepatitis. In November 2013, Schrödinger, in collaboration with Cycle ComputingEfruxifermin (459 words) [view diff] exact match in snippet view article find links to article
treat metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), and type 2 diabetes. EfruxiferminVolixibat (244 words) [view diff] exact match in snippet view article find links to article
medication under development as a possible treatment for nonalcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD)Clesacostat (1,469 words) [view diff] exact match in snippet view article find links to article
treatment of metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), with liver fibrosis. It is a liver-targetedHEC88473 (135 words) [view diff] exact match in snippet view article find links to article
developed by the Chinese company HEC Pharm for diabetes and non-alcoholic steatohepatitis. Pan, Qi; Lin, Shushan; Li, Yu; Liu, Liang; Li, Xiaoping; Gao, Xianglei;Pegozafermin (312 words) [view diff] exact match in snippet view article find links to article
glycopegylated FGF21 analog developed for the treatment of nonalcoholic steatohepatitis and hypertriglyceridemia. Loomba, Rohit; Sanyal, Arun J.; Kowdley,Ervogastat (173 words) [view diff] exact match in snippet view article find links to article
O-acyltransferase 2 inhibitor developed by Pfizer for non-alcoholic steatohepatitis. Its development was previously halted by the company but resumed inBelapectin (233 words) [view diff] exact match in snippet view article find links to article
developed by Galectin Therapeutics for the treatment of non-alcoholic steatohepatitis. In a phase 2b/3 trial belapectin at 2 mg/kg/LBW reduces varices developmentHEC96719 (182 words) [view diff] exact match in snippet view article find links to article
tricyclic farnesoid X receptor agonist developed for non-alcoholic steatohepatitis. Cao, Shengtian; Yang, Xinye; Zhang, Zheng; Wu, Junwen; Chi, Bo; ChenResmetirom (761 words) [view diff] exact match in snippet view article find links to article
noncirrhotic metabolic dysfunction associated steatohepatitis (MASH) (formerly known as nonalcoholic steatohepatitis NASH). It is structurally similar to theElafibranor (996 words) [view diff] exact match in snippet view article find links to article
type 2 diabetes, dyslipidemia, and metabolic dysfunction–associated steatohepatitis. "Iqirvo (Ipsen Pty Ltd)". Therapeutic Goods Administration (TGA).Omesdafexor (159 words) [view diff] exact match in snippet view article find links to article
small-molecule farnesoid X receptor (FXR) agonist developed for nonalcoholic steatohepatitis and colitis. Harrison, S. A.; Bashir, M. R.; Lee, K. J.; Shim-LopezVK2809 (243 words) [view diff] exact match in snippet view article find links to article
Therapeutics in a phase II trial for the treatment of nonalcoholic steatohepatitis and is also being investigated for glycogen storage disease type IaHU6 (403 words) [view diff] exact match in snippet view article find links to article
fat in humans with risk factors for metabolic dysfunction-associated steatohepatitis. In a phase 2a trial, the higher dosage levels reduced liver fat onEfocipegtrutide (200 words) [view diff] exact match in snippet view article find links to article
peptide 1 receptors. It is being studied for obesity and nonalcoholic steatohepatitis. Kalra, Sanjay; Bhattacharya, Saptarshi; Kapoor, Nitin (August 2021)Metreleptin (1,092 words) [view diff] exact match in snippet view article find links to article
In a clinical study, metreleptin treatment improved non-alcoholic steatohepatitis (fatty liver disease) both in patients with partial lipodystrophy andMelissa Palmer (999 words) [view diff] exact match in snippet view article find links to article
where she was in charge of the global development of Non-alcoholic steatohepatitis (NASH) and other liver disease programs. Prior to joining the pharmaceuticalHepatocellular carcinoma (10,359 words) [view diff] exact match in snippet view article find links to article
include hepatitis infection such as (hepatitis B, C or D), non-alcoholic steatohepatitis (NASH), alcoholic liver disease, or exposure to toxins such as aflatoxinAldafermin (370 words) [view diff] exact match in snippet view article find links to article
fibroblast growth factor 19 (FGF19) analogue developed for non-alcoholic steatohepatitis. Babu, A.F.; Iannone, V.; Lok, J.; Gomez-Gallego, C.; D'Auria, G.;ZED1227 (168 words) [view diff] exact match in snippet view article find links to article
inhibitor developed by Zedira GmbH for celiac disease and nonalcoholic steatohepatitis. Schuppan, Detlef; Mäki, Markku; Lundin, Knut E.A.; Isola, Jorma; Friesing-SosnikRencofilstat (232 words) [view diff] exact match in snippet view article find links to article
inhibitor and analog of cyclosporine A developed for nonalcoholic steatohepatitis and hepatocellular carcinoma. Harrison, Stephen A.; Mayo, Patrick RPrimary biliary cholangitis (6,163 words) [view diff] exact match in snippet view article find links to article
are absent, or when co-existent autoimmune hepatitis or nonalcoholic steatohepatitis is suspected. Liver biopsy can be useful to stage the disease for fibrosisInterleukin 19 (1,943 words) [view diff] exact match in snippet view article find links to article
is an essential regulator of neutrophil development. Nonalcoholic steatohepatitis (NASH) is a disease that has progressed from nonalcoholic fatty liverLicogliflozin (183 words) [view diff] exact match in snippet view article find links to article
as treating symptoms of polycystic ovary syndrome and nonalcoholic steatohepatitis. Zaki AM, Abo-Elnour DE, Abdalla YE, Hassan RY, Salama MK, ElboraayDenifanstat (313 words) [view diff] exact match in snippet view article find links to article
it has been tested in various types of cancer and for non-alcoholic steatohepatitis. Falchook, Gerald; Infante, Jeffrey; Arkenau, Hendrik-Tobias; PatelZSP1601 (174 words) [view diff] exact match in snippet view article find links to article
inhibitor developed by Guangdong Raynovent Biotech for nonalcoholic steatohepatitis. Zhu, Xiaoxue; Wu, Min; Wang, Hong; Li, Haijun; Lin, Junjie; Peng,Claudio Tiribelli (823 words) [view diff] exact match in snippet view article find links to article
population" "Molecular basis and mechanisms of progression of nonalcoholic steatohepatitis (NASH)" "Intestinal Integrity, the Microbiome and Inflammation" WatchkoDA-1241 (274 words) [view diff] exact match in snippet view article find links to article
developed by the South Korean company Dong-A ST for non-alcoholic steatohepatitis and type 2 diabetes. Lee, Seung-Ho; Park, Hansu; Yang, Eun-Kyoung;FibroTest (1,622 words) [view diff] exact match in snippet view article find links to article
co-infection, alcoholic liver diseases (steatosis and steatohepatitis), and non-alcoholic steatohepatitis (diabetes, overweight, hypertriglyceridemia, hypercholesterolemiaM30-Apoptosense ELISA (738 words) [view diff] exact match in snippet view article find links to article
Measure hepatocyte apoptosis to aid the diagnosis of non-alcoholic steatohepatitis (NASH) and steatosis in patients with hepatitis C virus infection.Miricorilant (463 words) [view diff] exact match in snippet view article find links to article
antagonist. It was developed by Corcept Therapeutics for nonalcoholic steatohepatitis and weight gain associated with atypical antipsychotics. CORT-108297Blount's disease (904 words) [view diff] exact match in snippet view article find links to article
mellitus, idiopathic intracranial hypertension (IIH), nonalcoholic steatohepatitis, SCFE, GERD, and hypertension. Blount disease is named after WalterPXL065 (485 words) [view diff] exact match in snippet view article find links to article
(d-R-pioglitazone) is a drug candidate for the treatment of nonalcoholic steatohepatitis (NASH). It is the deuterium-stabilized (R)-enantiomer of pioglitazoneCinchonine (194 words) [view diff] exact match in snippet view article find links to article
Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis". Drug Design, Development and Therapy. 17: 1417–1432. doi:10.2147/DDDTSUCNR1 (8,860 words) [view diff] exact match in snippet view article find links to article
hyperlipidemia but not from excessive alcohol consumption. Nonalcoholic steatohepatitis (i.e., NASH), now termed steatotic liver disease (i.e., SLD), is aSodium nitrate (1,740 words) [view diff] exact match in snippet view article find links to article
sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis". Journal of Alzheimer's Disease. 17 (3): 519–29. doi:10.3233/JAD-2009-1070Pegipanermin (305 words) [view diff] exact match in snippet view article find links to article
been reported for other neurodegenerative disorders, non-alcoholic steatohepatitis, or solid tumors. Development was discontinued for Parkinson's diseaseFormaldehyde dehydrogenase (1,271 words) [view diff] exact match in snippet view article find links to article
antigen. Assessing the gene expression of the ADHs in nonalcoholic steatohepatitis (NASH) patients has shown elevated levels of all ADHs, but primarilyList of hepato-biliary diseases (435 words) [view diff] exact match in snippet view article find links to article
vein granulomatous hepatitis berylliosis sarcoidosis nonalcoholic steatohepatitis (NASH) This may cause fatty liver, hepatitis, fibrosis and sclerosisS-Nitrosoglutathione (1,518 words) [view diff] exact match in snippet view article find links to article
crucial role in the pathogenesis of liver diseases including steatosis, steatohepatitis, and fibrosis. The ease of reversibility and the interplay of S-nitrosatingLDL receptor (3,036 words) [view diff] exact match in snippet view article find links to article
in the pathophysiology of atherosclerosis, metabolic syndrome, and steatohepatitis. Previously, rare mutations in LDL-genes have been shown to contributeAlimentiv (355 words) [view diff] exact match in snippet view article find links to article
Summit Clinical Research Announce Collaboration to drive Non-Alcoholic Steatohepatitis (NASH) Clinical Trials". Retrieved 30 April 2024. Cision (3 NovemberAnandamide (2,365 words) [view diff] exact match in snippet view article find links to article
found in people with nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and liver fibrosis. The American Academy of Dermatology has namedGLP-1 receptor agonist (5,861 words) [view diff] exact match in snippet view article find links to article
approved by the FDA to treat MASH (metabolic dysfunction-associated steatohepatitis) with stage 2 or stage 3 fibrosis of the liver. The mechanism of actionLeronlimab (1,775 words) [view diff] exact match in snippet view article find links to article
pre-clinical study of Leronlimab (PRO 140) to prevent nonalcoholic steatohepatitis with The Cleveland Clinic. In November, the company reported positiveMichael Roden (1,666 words) [view diff] exact match in snippet view article find links to article
Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis". Diabetes Care. 41 (6): 1235–1243. doi:10.2337/dc17-1318. ISSN 0149-5992Gilead Sciences (7,797 words) [view diff] exact match in snippet view article find links to article
agonists in the treatment of liver diseases such as non-alcoholic steatohepatitis. It bought EpiTherapeutics for $65 million. This acquisition gave GileadGRAMD1C (362 words) [view diff] exact match in snippet view article find links to article
onset of a form of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH) in mice. The VASt domain is responsible for binding cholesterolAmarin Corporation (885 words) [view diff] exact match in snippet view article find links to article
see, if it has an effect on Alzheimer, Colon Cancer, Nonalcoholic Steatohepatitis (NASH), and other diseases. HLS Therapeutics, Amarin´s license partnerDeuterated drug (1,537 words) [view diff] exact match in snippet view article find links to article
rare metabolic diseases, is developing PXL065 to target nonalcoholic steatohepatitis (NASH). The company acquired PXL065 (the deuterium-stabilized (R)-enantiomerAmycretin (575 words) [view diff] exact match in snippet view article find links to article
(2024). "Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists"Autoimmune hepatitis (3,770 words) [view diff] exact match in snippet view article find links to article
injury on liver biopsy and can help distinguish the two Nonalcoholic steatohepatitis - related medical history and liver biopsy showing fatty infiltrationFM101 (176 words) [view diff] exact match in snippet view article find links to article
Through Regulation of Adenosine a3 Receptor Signaling in Non-alcoholic Steatohepatitis". The FASEB Journal. 34 (S1): 1. doi:10.1096/fasebj.2020.34.s1.03837VK2735 (176 words) [view diff] exact match in snippet view article find links to article
(2024). "Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists"Ulrike Protzer (1,001 words) [view diff] exact match in snippet view article find links to article
Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes, Cancer Cell (2014)SH3BP5 (651 words) [view diff] exact match in snippet view article find links to article
Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis". Hepatology. 74 (6): 3127–3145. doi:10.1002/hepBritish Transplantation Society (612 words) [view diff] exact match in snippet view article find links to article
Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis. Gut 2012; 61(4): 484-500. "NICE Evidence Search | british transplantMichael Karin (674 words) [view diff] exact match in snippet view article find links to article
development is promoted by the common metabolic disorder non-alcoholic steatohepatitis (NASH). Using the so-called MUP-uPA mouse they demonstrated that NASHFree fatty acid receptor 4 (7,964 words) [view diff] exact match in snippet view article find links to article
acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment". Biomedicine & Pharmacotherapy. 144 112298. doi:10HRS9531 (181 words) [view diff] exact match in snippet view article find links to article
November 2023). "Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists"Cahill cycle (1,756 words) [view diff] exact match in snippet view article find links to article
diseases such as Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic steatohepatitis (NASH), and Type 2 Diabetes. A current active area of research is attemptingAcetyl-CoA carboxylase (3,043 words) [view diff] exact match in snippet view article find links to article
company Gilead as part of a combination treatment for non-alcoholic steatohepatitis (NASH), believed to be an increasing cause of liver failure. In additionArcturus Therapeutics (1,801 words) [view diff] exact match in snippet view article find links to article
in collaboration with Takeda to develop medicines for non-alcoholic steatohepatitis (NASH) and other gastrointestinal disorders. Lunar-RPL is a projectNancy Ascher (935 words) [view diff] exact match in snippet view article find links to article
episode focusses on the case of Maria, a patient with a nonalcoholic steatohepatitis and her 22 year old daughter Adriana. Ascher performed the removalGiaconda (pharmaceutical company) (859 words) [view diff] exact match in snippet view article
could be used to treat primary biliary cirrhosis and non-alcoholic steatohepatitis. Giaconda had initially envisaged using ursodeoxycholic acid as theTipelukast (175 words) [view diff] exact match in snippet view article find links to article
1 and LOXL2 mRNA overexpression in an advanced NASH (nonalcoholic steatohepatitis) model: LB-28". Hepatology. 60 (6): 1283A. ISSN 0270-9139. Bascom,Novo Nordisk (4,069 words) [view diff] exact match in snippet view article find links to article
company focusing on the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Novo Nordisk is involved in government funded collaborativeInsulin resistance (6,810 words) [view diff] exact match in snippet view article find links to article
diabetes: what causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis?". Journal of Gastroenterology and Hepatology. 25 (10): 1594–7. doi:10Sirtuin 1 (3,117 words) [view diff] exact match in snippet view article find links to article
repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis". European Journal of Pharmacology. 727: 115–24. doi:10.1016/j.ejpharThyromimetic (312 words) [view diff] exact match in snippet view article find links to article
2020). "Thyromimetics as emerging therapeutic agents for nonalcoholic steatohepatitis: rationale for the development of resmetirom (MGL-3196)". Expert OpinionAmira (software) (3,666 words) [view diff] exact match in snippet view article
Werven, J.; Nederveen, A.; Lamers, W.H. (2011). "Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease" (PDF)Ileal sodium/bile acid cotransporter (1,037 words) [view diff] exact match in snippet view article find links to article
and volixibat, under development for the treatment of nonalcoholic steatohepatitis. Elobixibat Linerixibat Maralixibat Odevixibat Ritivixibat VolixibatLipopolysaccharide (7,279 words) [view diff] exact match in snippet view article find links to article
the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis". Obesity Surgery. 17 (10): 1374–1380. doi:10.1007/s11695-007-9243-7Michael E. Busch (2,656 words) [view diff] exact match in snippet view article find links to article
Center, where he died from complications of pneumonia and non-alcoholic steatohepatitis on April 7. Maryland Governor Larry Hogan ordered flags to be flownARO-HSD (287 words) [view diff] exact match in snippet view article find links to article
an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis". Journal of Hepatology. 78 (4): 684–692. doi:10.1016/j.jhep.2022.11Liver (10,357 words) [view diff] exact match in snippet view article find links to article
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review". Hepatology. 77 (4): 1335–1347. doi:10Firsocostat (197 words) [view diff] exact match in snippet view article find links to article
acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)". Expert Opinion on Investigational Drugs. 29 (2): 135–141.Namodenoson (225 words) [view diff] exact match in snippet view article find links to article
double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis". Alimentary Pharmacology & Therapeutics. 54 (11–12): 1405–1415. doi:10Free fatty acid receptor (2,806 words) [view diff] exact match in snippet view article find links to article
acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment". Biomedicine & Pharmacotherapy. 144 112298. doi:10Roche (7,034 words) [view diff] exact match in snippet view article find links to article
inhibitors developed to fight inflammatory diseases like non-alcoholic steatohepatitis and liver fibrosis. In February 2019, the business announced it wouldHarrison's Principles of Internal Medicine (4,508 words) [view diff] exact match in snippet view article find links to article
Disease Chapter 336: Nonalcoholic Fatty Liver Diseases and Nonalcoholic Steatohepatitis Chapter 337: Cirrhosis and Its Complications Chapter 338: Liver TransplantationMetadoxine (1,907 words) [view diff] exact match in snippet view article find links to article
2014). "Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial". Journal of Clinical and ExperimentalInterleukin 6 (7,483 words) [view diff] exact match in snippet view article find links to article
Tsukamoto H (February 2019). "Inflammatory pathways in alcoholic steatohepatitis". Journal of Hepatology. 70 (2): 249–259. doi:10.1016/j.jhep.2018.10NFE2L1 (3,628 words) [view diff] exact match in snippet view article find links to article
inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia". Proceedings of the National Academy of SciencesCholine kinase (2,105 words) [view diff] exact match in snippet view article find links to article
phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis". Cell Metabolism. 3 (5): 321–31. doi:10.1016/j.cmet.2006.03.007. PMID 16679290Glycerol-3-phosphate dehydrogenase 1 (658 words) [view diff] exact match in snippet view article find links to article
(2014). "A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia". Eur. J. Hum. Genet. 22 (10): 1229–32. doi:10TERN-501 (109 words) [view diff] exact match in snippet view article find links to article
the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis". TouchREVIEWS in Endocrinology. 19 (1): 60–70. doi:10.17925/EE.2023Crohn's disease (18,529 words) [view diff] exact match in snippet view article find links to article
cirrhosis and steatosis. Nonalcoholic fatty liver disease (nonalcoholic steatohepatitis, NAFLD) are relatively common and can slowly progress to end-stageDetlef Schuppan (1,365 words) [view diff] exact match in snippet view article find links to article
severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis". Gastroenterology. 143 (2): 448–458. doi:10.1053/j.gastro.2012.04Zeynel Mungan (2,733 words) [view diff] exact match in snippet view article find links to article
fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? J Gastroenterol Hepatol. 25:619-26 (2010) Yonal O, Akyuz F, DemirAzemiglitazone (242 words) [view diff] exact match in snippet view article find links to article
Howard C. (April 2020). "Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study". JournalVitamin D deficiency (7,809 words) [view diff] exact match in snippet view article find links to article
between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis". International Journal of Clinical andZLY18 (254 words) [view diff] exact match in snippet view article find links to article
and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)". Signal Transduction and Targeted Therapy. 7 (1): 287Kang-Yell Choi (1,700 words) [view diff] exact match in snippet view article find links to article
focused on developing therapies for conditions such as non-alcoholic steatohepatitis (NASH), hair loss, and diabetic wounds, which are associated with impairedPlasmodium berghei (2,673 words) [view diff] exact match in snippet view article find links to article
Yu J (September 2016). "C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication". ExpertTamoxifen (9,322 words) [view diff] exact match in snippet view article find links to article
Osman MM, Ahmed MH (January 2007). "Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?". Expert Opinion on DrugAlström syndrome (4,115 words) [view diff] exact match in snippet view article find links to article
liver disease is common in AS. This often progresses to non-alcoholic steatohepatitis. Upper and lower respiratory tract infections in childhood, which decreaseMetformin (15,190 words) [view diff] exact match in snippet view article find links to article
patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlledFree fatty acid receptor 1 (7,552 words) [view diff] exact match in snippet view article find links to article
exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis". PLOS ONE. 17 (11) e0277251. Bibcode:2022PLoSO..1777251L. doi:10.1371/journalBariatric surgery (10,565 words) [view diff] exact match in snippet view article find links to article
type 2 diabetes, idiopathic intracranial hypertension, nonalcoholic steatohepatitis, Blount disease, slipped capital femoral epiphysis, gastroesophagealGalectin-3 (3,967 words) [view diff] exact match in snippet view article find links to article
(belapectin) failed phase 3 human clinical trials for nonalcoholic steatohepatitis (NASH). Earlier phase 1 data for belapectin showed increased effectivenessGram domain containing 1b (1,454 words) [view diff] exact match in snippet view article find links to article
onset of a form of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH) in mice. A study tagging SNPs from chronic lymphocytic leukemiaJHU-083 (561 words) [view diff] exact match in snippet view article find links to article
H (December 2022). "Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism". Biochemical and Biophysical ResearchAXA1125 (309 words) [view diff] exact match in snippet view article find links to article
composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models". Scientific Reports. 11 (1): 1186115-Hydroxyeicosatetraenoic acid (7,361 words) [view diff] exact match in snippet view article find links to article
Wierling, C (2014). "Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains". PLOS ONE. 9 (10) e111006. Bibcode:2014PLoSOOsteopontin (8,365 words) [view diff] exact match in snippet view article find links to article
of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis". Toxicology and Applied Pharmacology. 207 (1): 25–38. Bibcode:2005ToxAPJD5037 (528 words) [view diff] exact match in snippet view article find links to article
receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis". Regulatory Toxicology and Pharmacology. 109 104483. doi:10.1016/jGerald I. Shulman (3,058 words) [view diff] exact match in snippet view article find links to article
steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), type 2 diabetes (T2D), and related cardiometabolic conditionsYu-Jui Yvonne Wan (764 words) [view diff] exact match in snippet view article find links to article
which affects the development of metabolic dysfunction-associated steatohepatitis (MASH) and Hepatocellular carcinoma (HCC). She also studies the dietaryStefano Bellentani (1,138 words) [view diff] exact match in snippet view article find links to article
and their more severe forms, such as cirrhosis and non-alcoholic steatohepatitis (NASH). In a 1982 study, he explored the susceptibility of chronicBifidobacterium adolescentis (1,801 words) [view diff] exact match in snippet view article find links to article
2021). "Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity". Frontiers inList of drugs granted breakthrough therapy designation (248 words) [view diff] exact match in snippet view article find links to article
exercise, for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stagesAlexei Kharitonenkov (2,464 words) [view diff] exact match in snippet view article find links to article
dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis". eBioMedicine. 63 103202. doi:10.1016/j.ebiom.2020.103202. ISSN 2352-3964Scientist of the Month (393 words) [view diff] exact match in snippet view article find links to article
University Pharmacology Research on mechanisms of fatty liver and steatohepatitis and new therapeutic drug classes March Ham Byeongseung (함병승) Inha University2024 in science (27,690 words) [view diff] exact match in snippet view article find links to article
phase 3-trialed resmetirom as first medication against nonalcoholic steatohepatitis of the liver (7 Feb), a blood test against heart attacks, the top cause